Diffusion Pharmaceuticals
DFFN
#10455
Rank
S$11.54 M
Marketcap
S$5.66
Share price
10.28%
Change (1 day)
-37.18%
Change (1 year)

Earnings for Diffusion Pharmaceuticals (DFFN)

Earnings in 2023 (TTM): -S$17.79 Million

According to Diffusion Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -S$20.05 Million, an increase over its 2021 earnings that were of -S$31.55 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Diffusion Pharmaceuticals from 1999 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -S$17.79 Million-11.3%
2022 -S$20.05 Million-36.46%
2021 -S$31.55 Million54.72%
2020 -S$20.4 Million38.32%
2019 -S$14.75 Million-39.03%
2018 -S$24.18 Million677.09%
2017 -S$3.12 Million-86.85%
2016 -S$23.66 Million-22.75%
2015 -S$30.63 Million38.74%
2014 -S$22.08 Million598.54%
2013 -S$3.17 Million-57.56%
2012 -S$7.45 Million-62.43%
2011 -S$19.82 Million58.75%
2010 -S$12.49 Million238.41%
2009 -S$3.69 Million189.55%
2008 -S$1.28 Million1576.75%
2007 -S$0.08 Million-35.01%
2006 -S$0.12 Million
1999 -S$9.42 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-S$0.2 Billion 1,031.69%๐Ÿ‡บ๐Ÿ‡ธ USA